Strategic Use of Biodegradable Temporizing Matrix (BTM) in Wound Healing: A Case Series in Asian Patients
Source abstract
Abstract
Skin and soft tissue reconstruction has long been based on the reconstructive ladder. However, a skin substitute has become popular due to its predictable outcomes, without donor-site morbidity. The biodegradable temporizing matrix (BTM; NovoSorb, PolyNovo Ltd., Port Melbourne, Australia) is a synthetic skin substitute that has recently gained its clinical application. Compared with those of other dermal templates, the clinical efficacy and performance of the BTM are not well established, especially among the Asian population. This study aims to share our experience and strategy of using BTM in various wound conditions. The data of patients who underwent skin and soft tissue reconstruction with BTM at a single institution between January 2022 and December 2023 were reviewed. The patient demographics, wound characteristics, surgical details, secondary procedures, and complications were recorded and analyzed. Postoperative 6-month photographs were collected and independently evaluated by two plastic surgeons and two wound care center nurses using the Manchester Scar Scale (MSS). This study included 37 patients, consisting of 22 males and 15 females with a mean age of 51.8 years (range, 18–86 years old). The wound etiologies included trauma (67.6%), necrotizing soft tissue infection (16.2%), burns (10.8%), toe gangrene (2.7%), and scar excision (2.7%). The average wound area covered by BTM was 50.6 ± 47.6 cm2. Among the patients, eight received concomitant flap surgery and BTM implantation, 20 (54.1%) underwent subsequent split-thickness skin grafts (STSG), and 17 had small wounds (mean: 21.6 cm2) healed by secondary intention. Infection was the most common complication, affecting six patients (n = 6 [16.2%]), five of whom were treated conservatively, and only one required debridement. Thirty-three patients (89.2%) had good BTM take, and only four had BTM failure, requiring further reconstruction. At the last follow-up, 35 out of the 37 patients (94.6%) achieved successful wound closure, and the total MSS score was 10.44 ± 2.94, indicating a satisfactory scar condition. The patients who underwent BTM grafting without STSG had better scar scores than those who received STSG (8.71 ± 2.60 vs. 11.18 ± 2.84, p = 0.039). In conclusion, the BTM is effective and feasible in treating various wounds, with relatively low complication rates, and it can thus be considered as an alternative for skin and soft tissue reconstruction. When combined with adipofasical flap reconstruction, it achieves a more comprehensive anatomical restoration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Surgical Sutures and Adhesives · Reconstructive Surgery and Microvascular Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan
Division of Plastic and Aesthetic Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan
Department of Information Management, Yuan Ze University, Taoyuan 320, Taiwan
School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
References (30)
Show source-provided references
1. Biological background of dermal substitutes10.1016/j.burns.2009.07.012 ↗
2. Skin substitutes as treatment for chronic wounds: Current and future directions10.3389/fmed.2023.1154567 ↗
3. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study10.1016/j.burns.2021.07.014 ↗
4. NovoSorb Biodegradable Temporizing Matrix for Reconstruction of Multiplanar Degloving Injury of the Upper Limb10.1097/GOX.0000000000004909 ↗
5. The evolution of acute burn care—Retiring the split skin graft
6. A randomized, controlled trial of negative pressure wound therapy of pressure ulcers via a novel polyurethane foam10.1111/wrr.12146 ↗
7. A consecutive case series of defects reconstructed using NovoSorb® Biodegradable Temporising Matrix: Initial experience and early results10.1016/j.bjps.2020.05.067 ↗
8. Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds10.1111/ans.16936 ↗
9. A biodegradable polyurethane dermal matrix in reconstruction of free flap donor sites: A pilot study
10. A new quantitative scale for clinical scar assessment10.1097/00006534-199811000-00022 ↗
11. Skin substitutes: A review10.1016/S0305-4179(01)00018-3 ↗
12. Biologic and synthetic skin substitutes: An overview10.4103/0970-0358.70712 ↗
13. The use of dermal substitutes in burn surgery: Acute phase10.1111/wrr.12119 ↗
14. Artificial dermal templates: A comparative study of NovoSorb™ Biodegradable Temporising Matrix (BTM) and Integra ® Dermal Regeneration Template (DRT)10.1016/j.burns.2016.01.028 ↗
15. Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing10.3390/jfb6030547 ↗
16. Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR310.1111/j.1524-475X.2008.00439.x ↗
17. Dermal Regeneration Template in the Management and Reconstruction of Burn Injuries and Complex Wounds: A Review10.1097/GOX.0000000000005674 ↗
18. Banakh, I., Cheshire, P., Rahman, M., Carmichael, I., Jagadeesan, P., Cameron, N.R., Cleland, H., and Akbarzadeh, S. (2020). A Comparative Study of Engineered Dermal Templates for Skin Wound Repair in a Mouse Model. Int. J. Mol. Sci., 21.10.3390/ijms21124508 ↗
19. Performance of biodegradable temporizing matrix vs. collagen-chondroitin silicone bilayer dermal regeneration substitutes in soft tissue wound healing: A retrospective analysis10.25270/wnds/2022.106115 ↗
20. Experience with a synthetic bilayer Biodegradable Temporising Matrix in significant burn injury10.1016/j.burnso.2017.08.001 ↗
21. The Utility of Hypochlorous Acid Wound Therapy in Wound Bed Preparation and Skin Graft Salvage10.1097/PRS.0000000000005359 ↗
22. Split Skin Graft Take in Leg Ulcers: Conventional Dressing Versus Locally Adapted Negative Pressure Dressing10.1016/j.jss.2020.01.029 ↗
23. Negative pressure wound therapy (NPWT) is superior to conventional moist dressings in wound bed preparation for diabetic foot ulcers
24. Adipofascial perforator flaps: Its role in reconstruction of soft-tissue defects of lower leg and ankle10.4103/ijps.IJPS_19_17 ↗
25. Distally Based Sural Adipofascial Turnover Flap for Coverage of Complicated Wound in the Foot and Ankle Region10.1097/SAP.0000000000002069 ↗
26. The medial adipofascial flap for infected tibia fractures reconstruction: 10 years of experience with 59 cases10.1016/j.anplas.2020.07.010 ↗
27. Perforator-based Adipofascial Flaps and ADM: A Novel Combined Approach to Distal Lower Extremity Defects10.1097/GOX.0000000000004131 ↗
28. Immediate Application of Biodegradable Temporizing Matrix To a Muscle Free Flap for Complex Soft Tissue Reconstruction
29. Long-term scarring outcomes and safety of patients treated with NovoSorb® Biodegradable Temporizing Matrix (BTM): An observational cohort study10.1016/j.jpra.2023.05.003 ↗
30. Human hypertrophic scar-like nude mouse model: Characterization of the molecular and cellular biology of the scar process10.1111/j.1524-475X.2011.00672.x ↗